跳至主要内容
临床试验/NCT00368147
NCT00368147已完成不适用

Access Creation for Hemodialysis: Potential Contribution to Left Ventricular Remodelling

Ottawa Hospital Research Institute1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2002年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
84
试验地点
1

研究概览

简要总结

The purpose of this study is to determine if the creation of a fistula or a graft plays a role in the development of heart disease for patients undergoing hemodialysis

详细描述

Patients with end stage renal disease are at 18-20 times greater risk of dying from cardiovascular disease as the general population. Both traditional and non-traditional cardiovascular risk factors are thought to be important. Of the non-tradtional cardiovascular risk factors, creation of an arteriovenous fistula or graft for the purposes of a blood access for hemodialysis may contribute to an elevation in BNP and left ventricular hypertrophy - both factors that have been associated with an increased risk of mortality Prior to access creation and at one month and one year post access creation - samples for BNP will be collected Prior to access creation and at one year post access creation - echocardiography will be performed

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hemodialysis 2)high risk for heart failure (DM, age>50, and/or systolic dysfunction) 3) first arteriovenous fistula/graft 4) informed consent 5) technically adequate echocardiogram 6) stable hgb(>100) 7) stable mineral metabolism (normal calcium, phosphate <2.1mmol/L, PTH>50pmol/L)

排除标准

  • Expected survival <1 year 2) Expected to get a living donor transplant in one year 3)primary access failure 4) ARF

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Access Creation for Hemodialysis: Association With... | 临床试验